Arctic Business Incubator (Sweden)

Abstract Stocking of eggs is a common strategy to support declining or reintroduce extirpated salmonid populations. Data on how juveniles disperse from stocking points is crucial to be able to design efficient stocking programs. Detailed information of dispersal is limited for many salmonids, for example, brown trout. In this study, dispersal distance was measured at the end of the first growing season in a low gradient (0.7%) stream in Sweden where the trout population had been depleted. Eggs from 17 separate sets of parents were stocked as eyed eggs in March. During the following fall fry were sampled throughout the stream. The majority of the fry dispersed downstream and remained within a distance of 200 m from the stocking point with no difference between sizes of fry and the presence of a competing cohort or not. There was no dissimilarity in dispersal distances across offspring originating from different parents indicating absence of genetic influence. Our results suggest that, in streams similar to our study site, stocking points should be separated by approximately 330 m in order to avoid overlap in habitat use of fry from different stocking points and that the presence of competing cohorts, fry size and within population variability in dispersal can be neglected.

IntroductionThe association between lithium and thyroid dysfunction has long been known. Yet it is not known whether lithium-associated hypothyroidism is reversible, once lithium treatment has been stopped.ObjectivesTo determine whether lithium-associated hypothyroidism was reversible in patients who subsequently discontinued lithium.MethodsRetrospective cohort study in the Swedish region of Norrbotten into the effects and side- effects of lithium treatment and other drugs for relapse prevention (LiSIE). For this particular study, we reviewed medical records between 1997 and 2015 of patients treated with lithium.ResultsOf 1340 patients screened, we identified 90 patients with lithium-associated hypothyroidism who subsequently discontinued lithium. Of these, 27% had overt hypothyroidism at the time when thyroid replacement therapy was initiated. The mean delay from lithium start to thyroid replacement therapy start was 2.3 (SD 4.7) years. Fifty percent received thyroid replacement therapy within 10 months of starting lithium. Of 85 patients available for follow up, 35 (41%) stopped thyroid replacement therapy after lithium discontinuation. Six patients reinstated thyroid replacement therapy subsequently. Only one of these had overt hypothyroidism, occurring 13 days after stopping lithium and 11 days after stopping thyroid replacement therapy.ConclusionsLithium-associated hypothyroidism seems reversible in most patients, once lithium has been discontinued. In such cases, thyroid replacement therapy discontinuation could be attempted much more often than currently done. Based on the limited evidence of our study, we can expect hypothyroidism to recur early after discontinuation of thyroid replacement therapy if at all.DisclosureMO: scient adv. board member Astra Zeneca Sweden; UW: educ. activities Norrbotten Region: Astra Zeneca, Eli Lilly, Janssen, Novartis, Otsuka/Lundbeck, Servier, Shire and Sunovion. All others: none.

<p>Recent disruptions of raw material value chains during the  COVID-19 pandemic have highlighted Europe’s depency on imports of metals and minerals. Meanwhile, the European Commission is establishing ambitious policy initiatives, aiming at making Europe climate neutral in 2050. In this contribution, we emphasise the critical role of geosciences education in this energy transition, in forming the next generation of mining professionals. In the Nordic countries, active industry–university collaboration in one of the most active mining hubs in Europe has allowed frequent student–industry interaction, access to real-life learning environments, and development of specialised educational modules. These have been made accessible to exchange students from other European countries via exchange programmes and innovative digipedagogical learning tools.</p>

BackgroundLithium remains first choice as maintenance treatment for bipolar affective disorder. Yet, about half of all individuals may stop their treatment at some point, despite lithium’s proven benefits concerning the prevention of severe affective episodes and suicide.MethodsRetrospective cohort study in the Swedish region of Norrbotten into the causes of lithium discontinuation. The study was set up to (1) test whether patients with bipolar affective disorder or schizoaffective disorder, treated with lithium maintenance therapy, were more likely to discontinue lithium because of adverse effects than lack of therapeutic effectiveness, (2) explore gender differences, (3) understand the role of diagnosis and (4) identify who, patient or doctor, took the initiative to stop lithium. Review of medical records for all episodes of lithium discontinuation that had occurred between 1997 and 2013 with the intent to stop lithium for good.ResultsOf 873 patients treated with lithium, 54% discontinued lithium, corresponding to 561 episodes of lithium discontinuation. In 62% of episodes, lithium was discontinued due to adverse effects, in 44% due to psychiatric reasons, and in 12% due to physical reasons interfering with lithium treatment. The five single most common adverse effects leading to lithium discontinuation were diarrhoea (13%), tremor (11%), polyuria/polydipsia/diabetes insipidus (9%), creatinine increase (9%) and weight gain (7%). Women were as likely as men to take the initiative to stop lithium, but twice as likely to consult a doctor before taking action (p < 0.01). Patients with type 1 BPAD or SZD were more likely to discontinue lithium than patients with type 2 or unspecified BPAD (p < 0.01). Patients with type 1 BPAD or SZD were more likely to refuse medication (p < 0.01). Conversely, patients with type 2 or unspecified BPAD were three times as likely to discontinue lithium for lack or perceived lack of effectiveness (p < 0.001).ConclusionsStopping lithium treatment is common and occurs mostly due to adverse effects. It is important to discuss potential adverse effects with patients before initiation and continuously during lithium treatment, to reduce the frequency of potentially unnecessary discontinuations.